Cd276tm1.2Bcgen
Targeted Allele Detail
|
|
| Symbol: |
Cd276tm1.2Bcgen |
| Name: |
CD276 antigen; targeted mutation 1.2, Biocytogen LLC |
| MGI ID: |
MGI:7310467 |
| Gene: |
Cd276 Location: Chr9:58431581-58462720 bp, - strand Genetic Position: Chr9, 31.79 cM
|
| Alliance: |
Cd276tm1.2Bcgen page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:326342
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: Exons 3 and 4 were floxed and an FRT-flanked neo cassette was inserted via homologous recombination. Recombinase mediated recombination removed the neo cassette and exons 3 and 4.
(J:326342)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Cd276 Mutation: |
21 strains or lines available
|
|
| Original: |
J:326342 Cai D, et al., Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy. Cell Mol Immunol. 2020 Mar;17(3):227-236 |
| All: |
2 reference(s) |
|